SCHEMBL265674

SCHEMBL265674

C[C@@H]1CCC(=O)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5306053 1.00 CA1 (1.00) —
SCHEMBL37255 1.00 — —
SCHEMBL29465872 1.00 — —
SCHEMBL265331 1.00 — —
SCHEMBL28883290 0.97 — —
Water SCHEMBL28652816 0.97 — —
Methyl Alcohol SCHEMBL23272001 0.95 — —
Cyclohexane SCHEMBL29120104 0.93 CA1 (0.86) —
Benzene SCHEMBL28655502 0.93 CA1 (0.86) —
Dimethylamine SCHEMBL4684858 0.93 CA1 (0.86) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 — — US claimed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 — — EP claimed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 — — WO claimed
CN-121471055-A Method for synthesizing (R) -3-methylheptanoic acid 临沂大学 2026-02-06 — — CN disclosed
US-20250212873-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-07-03 — — US disclosed
CN-120142505-A Application of hydroxyapatite in pretreatment of fruit juice, sample pretreatment method and detection method of lactone compound in fruit juice 广州市名花香料有限公司 2025-06-13 — — CN disclosed
EP-4482306-A1 VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-01 — — EP disclosed
US-12037354-B2 Cyclic pantetheine derivatives and uses thereof VECTIVBIO COMET AG (CH) 2024-07-16 — — US disclosed
EP-4338761-A1 PERFUMING COMPOSITIONS Firmenich SA (CH) 2024-03-20 — — EP disclosed
WO-2023192424-A1 VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-10-05 — — WO disclosed
US-11730712-B2 Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease ESPERVITA THERAPEUTICS, INC. (US) 2023-08-22 — — US disclosed
US-20070043240-A1 Method for the synthesis of 4-hydroxyisoleucine and the derivatives thereof MIOSKOWSKI CHARLES 2007-02-22 — — US disclosed
WO-2006078724-A2 MACROCYCLIC ANALOGS FOR THE TREATMENT OF IMMUNOREGULATORY DISORDERS AND RESPIRATORY DISEASES ARRAY BIOPHARMA NC. (US) 2006-07-27 — — WO disclosed
US-20060160838-A1 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases ARRAY BIOPHARMA INC. 2006-07-20 — — US disclosed
US-20060030719-A1 Cis-3,5-disubstituted-dihydro-furan-2-ones and the preparation and use thereof E. I. DU PONT DE NEMOURS AND COMPANY 2006-02-09 — — US disclosed
WO-2005014565-A2 CIS-3,5-DISUBSTITUTED-DIHYDRO-FURAN-2-ONES AND THE PREPARATION AND USE THEREOF E.I. DUPONT DE NEMOURS AND COMPANY (US) 2005-02-17 — — WO disclosed
WO-2003103653-A1 METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 — — WO disclosed
EP-0478147-B1 Process for producing optically active gamma-butyrolactone derivatives TAKASAGO PERFUMERY CO LTD (JP) 1996-11-06 — — EP disclosed
US-5420306-A Process for producing optically active γ-butyrolactone derivatives TAKASAGO INTERNATIONAL CORPORATION (JP) 1995-05-30 — — US disclosed
EP-0478147-A1 Process for producing optically active gamma-butyrolactone derivatives Takasago International Corporation (JP) 1992-04-01 — — EP disclosed
Send feedback